Related references
Note: Only part of the references are listed.
Review
Health Care Sciences & Services
Martina Amanzio et al.
Summary: This systematic review compared the rates of adverse events (AEs) in the active and placebo groups of approved SARS-CoV-2 vaccines. The results showed that the occurrence of AEs was higher in the vaccine groups, and the most frequently reported AEs were fatigue, headache, local pain, and myalgia. These AEs were more common in the younger population and in the first dose of placebo recipients.
LANCET REGIONAL HEALTH-EUROPE
(2022)
Article
Biochemistry & Molecular Biology
Martina Patone et al.
Summary: Emerging reports of rare neurological complications associated with COVID-19 infection and vaccinations are leading to concerns in regulatory, clinical, and public health sectors. A self-controlled case series study in England showed an increased risk of rare neurological complications following COVID-19 vaccination and infection. The study highlighted a higher risk of Guillain-Barre syndrome after ChAdOx1nCoV-19 vaccination.
Article
Medicine, General & Internal
Anton Pottegard et al.
Summary: This study assessed rates of cardiovascular and haemostatic events in Denmark and Norway after vaccination with the Oxford-AstraZeneca vaccine ChAdOx1-S, finding increased rates of venous thromboembolic events among recipients. Despite slightly higher rates of thrombocytopenia/coagulation disorders and bleeding, the overall safety outcomes were largely reassuring.
BMJ-BRITISH MEDICAL JOURNAL
(2021)
Article
Clinical Neurology
Boby Maramattom et al.
Summary: In three districts of Kerala, India, around 1.5 million individuals have been vaccinated with COVID-19 vaccines, with over 80% receiving the ChAdOx1-S/nCoV-19 vaccine. Seven cases of Guillain-Barre syndrome (GBS) have been observed within this vaccinated population, with a frequency 1.4- to 10-fold higher than expected.
ANNALS OF NEUROLOGY
(2021)
Letter
Clinical Neurology
Talal Al-Mayhani et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
(2021)
Article
Medicine, General & Internal
Noam Barda et al.
Summary: The study found that after receiving the BNT162b2 vaccine, most adverse events were not associated with an increased risk, although there was a slight increase in the risk of myocarditis. On the other hand, infection with the Covid-19 virus significantly increased the risk of many serious adverse events.
NEW ENGLAND JOURNAL OF MEDICINE
(2021)